The role of surface energy in dry powders for inhalation: When does it matter?
Authors:
- Zeredescht MajidZMZeredescht Majid
- Thomas GutsmannTGThomas Gutsmann
- Christian NehlsCNChristian Nehls
- Thomas StrunskusTSThomas Strunskus
- Ricarda LeisterRLRicarda Leister
- Tristan MulTMTristan Mul
- Regina ScherließRSRegina Scherließ
Open Access
- 5 November 2026
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Influence of homolog composition and hydration states of magnesium stearate on carrier-based dry powder formulations for inhalationEuropean Journal of Pharmaceutical Sciences, 2025
- The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalersAdvanced Drug Delivery Reviews, 2012
- A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect?Advanced Drug Delivery Reviews, 2012
- Air permeability of powder: A potential tool for Dry Powder Inhaler formulation developmentEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- The Role of Force Control Agents in High-Dose Dry Powder Inhaler FormulationsJournal of Pharmaceutical Sciences, 2009
- The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphateEuropean Journal of Pharmaceutical Sciences, 2004
- Dry powder aerosol generation in different environments: Performance comparisons of albuterol, albuterol sulfate, albuterol adipate and albuterol stearateInternational Journal of Pharmaceutics, 1996
- Production of spray dried salbutamol sulphate for use in dry powder aerosol formulationInternational Journal of Pharmaceutics, 1994
- Deposition of particles in the human respiratory tract in the size range 0.005–15 μmJournal of Aerosol Science, 1986
- Dry Powder Aerosols I: A New Powder Inhalation DeviceJournal of Pharmaceutical Sciences, 1971